IDS will communicate with the investigator or study coordinator to ensure that patient enrollment, drug dispensing, and drug administration are consistent with the protocol.
Randomization of the patient to determine the correct drug and treatment regimen will occur promptly. The IDS can develop a patient randomization schedule if one is not provided in the study protocol.
Preparation of doses as described in the protocol. All study drugs are packaged to maintain blinding when required and to promote safe administration.
